Guizhou Bailing Group Pharmaceutical Co Ltd (002424) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.090x

Based on the latest financial reports, Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a cash flow conversion efficiency ratio of 0.090x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.76 Million ≈ $43.13 Million USD) by net assets (CN¥3.28 Billion ≈ $480.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Guizhou Bailing Group Pharmaceutical Co fund operations to measure how many days the company can operate on defensive assets alone.

Guizhou Bailing Group Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Guizhou Bailing Group Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guizhou Bailing Group Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Bailing Group Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen Shengxunda Technology Co Ltd Class A SHE:300518	0.020x
Bowhead Specialty Holdings Inc. NYSE:BOW	0.143x
Gujarat Narmada Valley Fertilizers and Chemicals Limited NSE:GNFC	0.033x
Tips Music Limited NSE:TIPSMUSIC	0.178x
Mingyue Optical Lens Co.Ltd. SHE:301101	N/A
Cullinan Oncology LLC NASDAQ:CGEM	-0.126x
GMR Power and Urban Infra Limited NSE:GMRP&UI	0.216x
Zhejiang Whwh SHG:600576	0.061x

Annual Cash Flow Conversion Efficiency for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Guizhou Bailing Group Pharmaceutical Co stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.17 Billion ≈ $464.57 Million	CN¥748.72 Million ≈ $109.56 Million	0.236x	+8263.87%
2024-12-31	CN¥3.20 Billion ≈ $468.14 Million	CN¥9.02 Million ≈ $1.32 Million	0.003x	-92.09%
2023-12-31	CN¥3.53 Billion ≈ $516.15 Million	CN¥125.77 Million ≈ $18.40 Million	0.036x	-71.62%
2022-12-31	CN¥4.00 Billion ≈ $584.87 Million	CN¥502.15 Million ≈ $73.48 Million	0.126x	+53.13%
2021-12-31	CN¥3.96 Billion ≈ $579.50 Million	CN¥324.92 Million ≈ $47.55 Million	0.082x	+38.77%
2020-12-31	CN¥3.92 Billion ≈ $573.66 Million	CN¥231.78 Million ≈ $33.92 Million	0.059x	-47.68%
2019-12-31	CN¥4.14 Billion ≈ $605.25 Million	CN¥467.41 Million ≈ $68.40 Million	0.113x	+381.70%
2018-12-31	CN¥3.92 Billion ≈ $574.31 Million	CN¥-157.45 Million ≈ $-23.04 Million	-0.040x	-274.11%
2017-12-31	CN¥3.47 Billion ≈ $507.36 Million	CN¥79.88 Million ≈ $11.69 Million	0.023x	-84.86%
2016-12-31	CN¥3.07 Billion ≈ $448.56 Million	CN¥466.62 Million ≈ $68.28 Million	0.152x	-1.24%
2015-12-31	CN¥2.68 Billion ≈ $392.31 Million	CN¥413.23 Million ≈ $60.47 Million	0.154x	-8.57%
2014-12-31	CN¥2.35 Billion ≈ $343.57 Million	CN¥395.83 Million ≈ $57.92 Million	0.169x	+153.01%
2013-12-31	CN¥2.13 Billion ≈ $311.30 Million	CN¥141.76 Million ≈ $20.74 Million	0.067x	+597.39%
2012-12-31	CN¥2.04 Billion ≈ $298.89 Million	CN¥19.52 Million ≈ $2.86 Million	0.010x	-90.82%
2011-12-31	CN¥1.94 Billion ≈ $283.94 Million	CN¥201.90 Million ≈ $29.54 Million	0.104x	+142.93%
2010-12-31	CN¥1.85 Billion ≈ $270.28 Million	CN¥-447.68 Million ≈ $-65.51 Million	-0.242x	-172.42%
2009-12-31	CN¥374.42 Million ≈ $54.79 Million	CN¥125.31 Million ≈ $18.34 Million	0.335x	+317.54%
2008-12-31	CN¥262.75 Million ≈ $38.45 Million	CN¥-40.42 Million ≈ $-5.92 Million	-0.154x	+64.59%
2007-12-31	CN¥182.68 Million ≈ $26.73 Million	CN¥-79.37 Million ≈ $-11.61 Million	-0.434x	--

About Guizhou Bailing Group Pharmaceutical Co Ltd

SHE:002424 China Drug Manufacturers - Specialty & Generic

Market Cap

$887.58 Million

CN¥6.07 Billion CNY

Market Cap Rank

#9598 Global

#2529 in China

Share Price

CN¥4.34

Change (1 day)

-1.36%

52-Week Range

CN¥4.09 - CN¥6.65

All Time High

CN¥28.52